Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retinol Binding Protein 4 Expression and Its Genetic Variants in Severe Alopecia Areata Treated With Barcitinib.

NCT06545110 is registered in ClinicalTrials.gov with South Valley University as lead sponsor.

NCT NCT06545110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06545110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retinol Binding Protein 4 Expression and Its Genetic Variants in Severe Alopecia Areata Treated With Barcitinib.
Lead sponsor
South Valley University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
October 30, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata